Krensavage Asset Management, LLC
CIK 0001609251
Annualised vol
13.885209%
Beta
0.395489
HHI
1028.626412
Top-10 weight
89.376688%
VaR 95%
1.305691%
VaR 99%
2.163704%
Max drawdown
17.652056%
Matched value
93.115343%
Returns of reported holdings
Loading returns…
Position changes vs prior quarter
What the latest 13F shows bought and sold against the quarter before, by share count.
| Ticker | Change | Shares now | Shares before | Share change % | Value now ($) |
|---|---|---|---|---|---|
| ENTA | UNCHANGED | 2,866,138 | 2,866,138 | 0.0% | 41,788 |
| JAZZ | UNCHANGED | 167,816 | 167,816 | 0.0% | 40,439 |
| UTHR | REDUCED | 69,282 | 84,282 | -17.8% | 37,539 |
| BMRN | UNCHANGED | 524,786 | 524,786 | 0.0% | 30,028 |
| EXEL | REDUCED | 370,693 | 415,693 | -10.83% | 20,169 |
| ABT | ADDED | 200,000 | 5,000 | 3900.0% | 18,148 |
| SNY | UNCHANGED | 323,946 | 323,946 | 0.0% | 13,820 |
| SUPN | UNCHANGED | 280,681 | 280,681 | 0.0% | 13,054 |
| VNDA | UNCHANGED | 1,180,388 | 1,180,388 | 0.0% | 7,224 |
| BNTX | UNCHANGED | 59,523 | 59,523 | 0.0% | 5,539 |
| BIIB | UNCHANGED | 20,000 | 20,000 | 0.0% | 4,321 |
| REGN | ADDED | 6,000 | 4,000 | 50.0% | 3,741 |
| EMBC | ADDED | 1,135,340 | 735,340 | 54.4% | 3,701 |
| ARDX | ADDED | 534,523 | 500,000 | 6.9% | 2,726 |
| INMD | UNCHANGED | 120,942 | 120,942 | 0.0% | 1,768 |
| EOLS | UNCHANGED | 157,985 | 157,985 | 0.0% | 1,096 |
| INDV | CLOSED OUT | 0 | 339,532 | -100.0% | 0 |
| ALKS | CLOSED OUT | 0 | 107,822 | -100.0% | 0 |
Holdings (latest quarter)
| Ticker | Change | Issuer | Class | CUSIP | Value ($) | Weight % | Shares |
|---|---|---|---|---|---|---|---|
| ENTA | UNCHANGED | ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 41,788 | 15.88 | 2866138.0 |
| JAZZ | UNCHANGED | JAZZ PHARMACEUTICALS PLC | COM | G50871105 | 40,439 | 15.36 | 167816.0 |
| UTHR | REDUCED | UNITED THERAPEUTICS CORP | COM | 91307C102 | 37,539 | 14.26 | 69282.0 |
| BMRN | UNCHANGED | BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 30,028 | 11.41 | 524786.0 |
| EXEL | REDUCED | EXELIXIS INC | COM | 30161Q104 | 20,169 | 7.66 | 370693.0 |
| ABT | ADDED | ABBOTT LABORATORIES | COM | 002824100 | 18,148 | 6.89 | 200000.0 |
| SNY | UNCHANGED | SANOFI-ADR | COM | 80105N105 | 13,820 | 5.25 | 323946.0 |
| SUPN | UNCHANGED | SUPERNUS PHARMACEUTICALS INC | COM | 868459108 | 13,054 | 4.96 | 280681.0 |
| - | ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 13,051 | 4.96 | 390879.0 | |
| VNDA | UNCHANGED | VANDA PHARMACEUTICALS INC | COM | 921659108 | 7,224 | 2.74 | 1180388.0 |
| BNTX | UNCHANGED | BIONTECH SE-ADR | COM | 09075V102 | 5,539 | 2.1 | 59523.0 |
| - | GSK PLC-SPON ADR | COM | 37733W204 | 5,071 | 1.93 | 96729.0 | |
| BIIB | UNCHANGED | BIOGEN INC | COM | 09062X103 | 4,321 | 1.64 | 20000.0 |
| REGN | ADDED | REGENERON PHARMACEUTICALS | COM | 75886F107 | 3,741 | 1.42 | 6000.0 |
| EMBC | ADDED | EMBECTA CORP | COM | 29082K105 | 3,701 | 1.41 | 1135340.0 |
| ARDX | ADDED | ARDELYX INC | COM | 039697107 | 2,726 | 1.04 | 534523.0 |
| INMD | UNCHANGED | INMODE LTD | COM | M5425M103 | 1,768 | 0.67 | 120942.0 |
| EOLS | UNCHANGED | EVOLUS INC | COM | 30052C107 | 1,096 | 0.42 | 157985.0 |
Quarterly portfolios
| Period | Filed | Value ($) | Positions | Vol % | Beta | Max DD % |
|---|---|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | 263,223 | 18 | 13.885209 | 0.395489 | 17.652056 |
| 2026-03-31 | 2026-05-15 | 255,697 | 20 | 13.957351 | 0.362323 | 18.100636 |
| 2025-12-31 | 2026-02-18 | 283,112 | 18 | 12.6551 | 0.34038 | 17.782291 |
| 2025-09-30 | 2025-11-17 | 234,698 | 17 | 12.931078 | 0.342838 | 18.421312 |
| 2025-03-31 | 2025-05-15 | 180,885 | 14 | 14.365492 | 0.363392 | 23.679216 |
| 2024-12-31 | 2025-02-18 | 169,025 | 12 | 17.305138 | 0.461822 | 26.75724 |